Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
Figure 6
Six months after the unsuccessful treatment, a further angiography confirmed a recurrence of a new polypoidal choroidal vasculopathy in the eye. (a) ICGA showed new multiple polypoidal lesions at the extrafoveal area. (b) Cirrus HD-OCT confirms a subfoveal serous retinal detachment and a small protrusion of the retinal pigment epithelium corresponding to the polyp.